Treat intended use as the first US regulatory question
FDA explains that products described as animal supplements are regulated as animal food or new animal drugs depending on intended use. Statements that imply treatment, prevention or mitigation of disease can create drug intent. A US project therefore begins by aligning formula direction, benefit language and evidence. The brand should also identify the states and channels in its launch plan because registration and label requirements can vary.
Separate federal, state and commercial evidence needs
Ingredient status, common names, ingredient order, net quantity, business details and directions belong in the label workflow. AAFCO model rules and definitions are influential but do not replace state law. Manufacturing specifications, batch COA, stability work and claim support should be mapped to the finished concept. Hytanbio supplies project evidence within scope; the US brand owner remains responsible for the legal launch and state registrations.